| FNARX | RYEIX | FNARX / RYEIX | |
| Total Expense Ratio | 0.69 | 1.38 | 50% |
| Annual Report Gross Expense Ratio | 0.69 | 1.43 | 48% |
| Fund Existence | 29 years | 28 years | - |
| Gain YTD | 37.508 | 41.264 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 919M | 27.5M | 3,342% |
| Annual Yield % from dividends | 1.78 | 1.88 | 94% |
| Returns for 1 year | 53.96 | 51.30 | 105% |
| Returns for 3 years | 80.48 | 49.23 | 163% |
| Returns for 5 years | 230.94 | 181.88 | 127% |
| Returns for 10 years | 175.46 | 84.57 | 207% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MYIIX | 12.04 | 0.10 | +0.84% |
| NYLI WMC International Research Eq Cl I | |||
| RYPDX | 108.38 | 0.64 | +0.59% |
| Rydex Consumer Products A | |||
| MIGKX | 42.07 | 0.21 | +0.50% |
| MFS Massachusetts Inv Gr Stk R4 | |||
| FBTIX | 55.70 | N/A | N/A |
| Fidelity Advisor Biotechnology I | |||
| ARYGX | 14.94 | -0.02 | -0.13% |
| American Century Global Real Estate R5 | |||